CVS gave adjusted earnings guidance of $7.90‑8.10 per share for the fiscal year. Previously, the guidance was $7.30‑7.50, and the market expected $7.45.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.